Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · MARLTON, NJ · NPI 1477533545
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 309 | 100 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 302 | 97 |
| Atorvastatin Calcium | Atorvastatin Calcium | 250 | 79 |
| Omeprazole | Omeprazole | 242 | 80 |
| Levothyroxine Sodium | Levothyroxine Sodium | 233 | 61 |
| Alprazolam | Alprazolam | 165 | 47 |
| Ibuprofen | Ibuprofen | 138 | 49 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 128 | 21 |
| Famotidine | Famotidine | 125 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 120 | 43 |
| Zolpidem Tartrate | Zolpidem Tartrate | 120 | 34 |
| Losartan Potassium | Losartan Potassium | 117 | 39 |
| Glimepiride | Glimepiride | 113 | 32 |
| Metformin Hcl | Metformin Hcl | 105 | 37 |
| Prednisone | Prednisone | 105 | 75 |
| Montelukast Sodium | Montelukast Sodium | 104 | 27 |
| Gabapentin | Gabapentin | 100 | 26 |
| Carvedilol | Carvedilol | 92 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 89 | 25 |
| Lisinopril | Lisinopril | 81 | 23 |
| Ozempic | Semaglutide | 81 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 80 | 40 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 80 | 19 |
| Celecoxib | Celecoxib | 79 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 79 | 20 |
| Hydrochlorothiazide | Hydrochlorothiazide | 79 | 29 |
| Lorazepam | Lorazepam | 73 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 72 | 17 |
| Tamsulosin Hcl | Tamsulosin Hcl | 71 | 26 |
| Azithromycin | Azithromycin | 70 | 61 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 69 | 50 |
| Oxycodone Hcl | Oxycodone Hcl | 65 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 61 | 18 |
| Pregabalin | Pregabalin | 57 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 56 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 55 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 50 | 12 |
| Tramadol Hcl | Tramadol Hcl | 50 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 50 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 49 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 49 | 11 |
| Eliquis | Apixaban | 48 | 13 |
| Potassium Chloride | Potassium Chloride | 48 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 47 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 44 | 12 |
| Irbesartan | Irbesartan | 43 | 12 |
| Metoprolol Tartrate | Metoprolol Tartrate | 43 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 43 | 22 |
| Telmisartan | Telmisartan | 42 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 39 | 18 |
| Mounjaro | Tirzepatide | 38 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 38 | 11 |
| Armodafinil | Armodafinil | 37 | suppressed |
| Ezetimibe | Ezetimibe | 37 | 13 |
| Januvia | Sitagliptin Phosphate | 37 | 11 |
| Trazodone Hcl | Trazodone Hcl | 37 | 11 |
| Meclizine Hcl | Meclizine Hcl | 36 | 16 |
| Allopurinol | Allopurinol | 35 | 11 |
| Mupirocin | Mupirocin | 35 | 22 |
| Atenolol | Atenolol | 34 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 34 | 22 |
| Methylprednisolone | Methylprednisolone | 32 | 23 |
| Metoclopramide Hcl | Metoclopramide Hcl | 32 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 31 | 12 |
| Diazepam | Diazepam | 30 | suppressed |
| Ketoconazole | Ketoconazole | 29 | 13 |
| Bupropion Xl | Bupropion Hcl | 28 | 12 |
| Topiramate | Topiramate | 28 | suppressed |
| Bumetanide | Bumetanide | 27 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 26 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 26 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 19 |
| Simvastatin | Simvastatin | 24 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 24 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 23 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Meloxicam | Meloxicam | 22 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 21 | 20 |
| Linzess | Linaclotide | 21 | suppressed |
| Memantine Hcl | Memantine Hcl | 21 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 19 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Jardiance | Empagliflozin | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 18 | suppressed |
| Furosemide | Furosemide | 18 | suppressed |
| Glipizide | Glipizide | 18 | suppressed |
| Xarelto | Rivaroxaban | 18 | suppressed |
| Testosterone | Testosterone | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 16 | 12 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 16 | suppressed |
| Clonazepam | Clonazepam | 15 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Lubiprostone | Lubiprostone | 15 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 14 | suppressed |
| Mirtazapine | Mirtazapine | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | suppressed |
| Telmisartan-Amlodipine | Telmisartan/Amlodipine | 13 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 13 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 13 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 12 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Finasteride | Finasteride | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
| Zaleplon | Zaleplon | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error